Literature DB >> 21085115

Developing treatments for female sexual dysfunction.

R Jordan1, T J Hallam, P Molinoff, C Spana.   

Abstract

Female sexual dysfunction (FSD) is a term that encompasses a collection of sexual disorders that can affect women throughout their adult life. FSD has multiple causes, with physiological,psychological, and social determinants.1 The complexity of the female sexual response with overlapping subjective and physiological components and the potential presence of sexual comorbidities present unique challenges for the design and conduct of randomized, controlled clinical studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21085115     DOI: 10.1038/clpt.2010.262

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  A manifesto on the preservation of sexual function in women and girls with cancer.

Authors:  Stacy Tessler Lindau; Emily M Abramsohn; Amber C Matthews
Journal:  Am J Obstet Gynecol       Date:  2015-03-25       Impact factor: 8.661

Review 2.  Flibanserin: First Global Approval.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2015-10       Impact factor: 9.546

3.  Peripheral Female Genital Arousal as Assessed by Thermography Following Topical Genital Application of Alprostadil vs Placebo Arousal Gel: A Proof-of-Principle Study Without Visual Sexual Stimulation.

Authors:  Sue W Goldstein; Joshua R Gonzalez; Catherine Gagnon; Irwin Goldstein
Journal:  Sex Med       Date:  2016-04-15       Impact factor: 2.491

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.